A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA)

TerminatedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

December 8, 2017

Primary Completion Date

September 14, 2018

Study Completion Date

September 14, 2018

Conditions
Axial Spondyloarthritis
Interventions
BEHAVIORAL

Active Supervised Training (AST)

The active supervised and standardized training consisted of 24 units of exercise within 20 weeks performed in certified training centers and was focused on back fitness, core strengthening and patient engagement to treat back pain and functional impairment.

BEHAVIORAL

Standard of Care (SOC) Physiotherapy

Standard of care physiotherapy as used in this study included active as well as passive training and massages according to the physiotherapist discretion.

Trial Locations (6)

10787

MVZ Wittenbergplatz PP Orthos /ID# 204802, Berlin

14467

Rheumahaus Studien GbR, Potsdam, DE /ID# 164494, Potsdam

22415

Praxis Ortho DE /ID# 204149, Hamburg

42105

Krankenhaus St. Josef /ID# 164501, Wuppertal

06128

Rheumapraxis /ID# 164461, Halle

04129

Praxis internistische Rheumato /ID# 164463, Leipzig

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY